Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours

por Naito, Yoichi, Nishida, Toshirou, Doi, Toshihiko
Publicado 2023

Recent Progress and Challenges in the Diagnosis and Treatment of Gastrointestinal Stromal Tumors

por Nishida, Toshirou, Yoshinaga, Shigetaka, Takahashi, Tsuyoshi, Naito, Yoichi
Publicado 2021

Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer

por Matsubara, Nobuaki, Mukai, Hirofumi, Naito, Yoichi, Nezu, Masahiko, Itoh, Kuniaki
Publicado 2013

Cisplatin and S‐1 for urachal carcinoma: A single‐institution case series

por Urasaki, Tetsuya, Naito, Yoichi, Matsubara, Nobuaki, Sasaki, Masaoki, Kogawa, Takahiro, Hosono, Ako
Publicado 2019

A phase 1 trial of xentuzumab, an IGF‐neutralizing antibody, in Japanese patients with advanced solid tumors

por Doi, Toshihiko, Kuboki, Yasutoshi, Naito, Yoichi, Ishida, Masahiro, Tanaka, Tetsuya, Takeuchi, Yoshito
Publicado 2022

A phase 1 study of crenigacestat (LY3039478), the Notch inhibitor, in Japanese patients with advanced solid tumors

por Doi, Toshihiko, Tajimi, Masaomi, Mori, Joji, Asou, Hiroya, Inoue, Koichi, Benhadji, Karim A., Naito, Yoichi
Publicado 2020

Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes

por Kobayashi, Eisuke, Naito, Yoichi, Asano, Naofumi, Maejima, Aiko, Endo, Makoto, Takahashi, Shunji, Megumi, Yasunori, Kawai, Akira
Publicado 2019

Phase 1 combination study of Eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer

por Mukai, Hirofumi, Saeki, Toshiaki, Shimada, Ken, Naito, Yoichi, Matsubara, Nobuaki, Nakanishi, Tadashi, Obaishi, Hiroshi, Namiki, Masayuki, Sasaki, Yasutsuna
Publicado 2014

Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer

por Sasaki, Akinori, Harano, Kenichi, Kogawa, Takahiro, Matsubara, Nobuaki, Naito, Yoichi, Hosono, Ako, Mukai, Hirofumi, Yoshino, Takayuki, Mukohara, Toru
Publicado 2020

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)

por Misawa, Sonoko, Denda, Tadamichi, Kodama, Sho, Suzuki, Takuji, Naito, Yoichi, Kogawa, Takahiro, Takada, Mamoru, Suichi, Tomoki, Shiosakai, Kazuhito, Kuwabara, Satoshi
Publicado 2023

Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world

por Nishida, Toshirou, Sakai, Yoshiharu, Takagi, Masakazu, Ozaka, Masato, Kitagawa, Yuko, Kurokawa, Yukinori, Masuzawa, Toru, Naito, Yoichi, Kagimura, Tatsuo, Hirota, Seiichi
Publicado 2019

Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study

por Naito, Yoichi, Kai, Yuichiro, Ishikawa, Takashi, Fujita, Tomoyuki, Uehara, Kanou, Doihara, Hiroyoshi, Tokunaga, Shinya, Shimokawa, Mototsugu, Ito, Yoshinori, Saeki, Toshiaki
Publicado 2019

Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study

por Doi, Toshihiko, Yamamoto, Noboru, Naito, Yoichi, Kuboki, Yasutoshi, Koyama, Takafumi, Piao, Yongzhe, Tsujimoto, Naoto, Asou, Hiroya, Inoue, Koichi, Kondo, Shunsuke
Publicado 2021

Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study

por Naito, Yoichi, Kuboki, Yasutoshi, Ikeda, Masafumi, Harano, Kenichi, Matsubara, Nobuaki, Toyoizumi, Shigeyuki, Mori, Yuko, Hori, Natsuki, Nagasawa, Takashi, Kogawa, Takahiro
Publicado 2021

The Safety of Chemotherapy for Breast Cancer Patients with Hepatitis C Virus Infection

por Miura, Yuji, Theriault, Richard L, Naito, Yoichi, Suyama, Koichi, Shimomura, Akihiko, Iwatani, Tsuguo, Miura, Daishu, Kawabata, Hidetaka, Kumada, Hiromitsu, Takano, Toshimi
Publicado 2013

Effect of food on the pharmacokinetics of TAS‐102 and its efficacy and safety in patients with advanced solid tumors

por Yoshino, Takayuki, Kojima, Takashi, Bando, Hideaki, Yamazaki, Tomoko, Naito, Yoichi, Mukai, Hirofumi, Fuse, Nozomu, Goto, Koichi, Ito, Yuko, Doi, Toshihiko, Ohtsu, Atsushi
Publicado 2016

Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma(†)

por Kawai, Akira, Araki, Nobuhito, Naito, Yoichi, Ozaki, Toshifumi, Sugiura, Hideshi, Yazawa, Yasuo, Morioka, Hideo, Matsumine, Akihiko, Saito, Kenichi, Asami, Shun, Isu, Kazuo
Publicado 2017

Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors

por Kawazoe, Akihito, Kuboki, Yasutoshi, Bando, Hideaki, Fukuoka, Shota, Kojima, Takashi, Naito, Yoichi, Iino, Shuichi, Yodo, Yasuhide, Doi, Toshihiko, Shitara, Kohei, Yoshino, Takayuki
Publicado 2020

Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors

por Doi, Toshihiko, Yang, James Chih-Hsin, Shitara, Kohei, Naito, Yoichi, Cheng, Ann-Lii, Sarashina, Akiko, Pronk, Linda C., Takeuchi, Yoshito, Lin, Chia-Chi
Publicado 2019

Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study

por Kato, Hidenori, de Souza, Paul, Kim, Sang-We, Lickliter, Jason D., Naito, Yoichi, Park, Keunchil, Kumar, Sanjeev, Mugundu, Ganesh M., Bang, Yung-Jue
Publicado 2020